PHAP1 promotes glioma cell proliferation by regulating the Akt/p27/stathmin pathway.
Ontology highlight
ABSTRACT: PHAP1 (Putative HLA-DR-associated protein 1), also termed acidic leucine-rich nuclear phosphoprotein 32A (ANP32A), Phosphoprotein 32 (pp32) or protein phosphatase 2A inhibitor (I1PP2A), is a multifunctional protein aberrantly expressed in multiple types of human cancers. However, its expression pattern and clinical relevance in human glioma remain unknown. In this study, Western blotting and immunohistochemistry analysis demonstrated PHAP1 protein was highly expressed in glioma patients, especially in those with high-grade disease. Publicly available data also revealed high levels of PHAP1 were associated with poor prognosis in glioma patients. The functional studies showed that knock-down of PHAP1 suppressed the proliferation of glioma cells, while overexpression of PHAP1 facilitated it.
SUBMITTER: Xie M
PROVIDER: S-EPMC6033192 | biostudies-literature | 2018 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA